Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Dovato (dolutegravir/lamivudine) for the Treatment of HIV Infection

Drug Name

Dovato® (dolutegravir/lamivudine)

Developer

ViiV Healthcare

Therapy Class

Integrase strand transfer and nucleoside analogue reverse transcriptase inhibitors

Current Indication

HIV-1 infection

Market Sector

Anti-infective

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top